Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...
Neuvivo, a late-clinical stage biopharmaceutical company, today announced promising results from two groundbreaking publications on its investigationa ...
The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...